Many single-payer (nationally funded) healthcare systems pay a lot less for drugs, services, and equipment than US insurers do. They have a monopsony and therefore a lot of buying power--makes sense, right? Erik recently has a revelation that calls this logic into question... though without any clear answers.

Support this show http://supporter.acast.com/reconsiderpodcast.

Hosted on Acast. See acast.com/privacy for more information.